| Literature DB >> 31358572 |
Anna Volkmer1, Emily Rogalski2,3, Maya Henry4, Cathleen Taylor-Rubin5,6, Leanne Ruggero5, Rebecca Khayum2, Jackie Kindell7, Maria Luisa Gorno-Tempini8,9, Jason D Warren10, Jonathan D Rohrer11.
Abstract
The term primary progressive aphasia (PPA) describes a group of neurodegenerative disorders with predominant speech and language dysfunction as their main feature. There are three main variants - the semantic variant, the nonfluent or agrammatic variant and the logopenic variant - each with specific linguistic deficits and different neuroanatomical involvement. There are currently no curative treatments or symptomatic pharmacological therapies. However, speech and language therapists have developed several impairment-based interventions and compensatory strategies for use in the clinic. Unfortunately, multiple barriers still need to be overcome to improve access to care for people with PPA, including increasing awareness among referring clinicians, improving training of speech and language therapists and developing evidence-based guidelines for therapeutic interventions. This review highlights this inequity and the reasons why neurologists should refer people with PPA to speech and language therapists. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: aphasia; frontotemporal dementia; primary progressive aphasia; speech therapy
Mesh:
Year: 2019 PMID: 31358572 PMCID: PMC6986989 DOI: 10.1136/practneurol-2018-001921
Source DB: PubMed Journal: Pract Neurol ISSN: 1474-7758